EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections

Michelle Hardman, Sarah Higgi, Liam Hanson, Kristin Schutz, Matthew J Wargo, Charlotte C Teneback, Thomas W V Daniels, Christopher van der Gast iD, Damian W Rivett iD

Microbiology Spectrum · 02.09.2025 · 13 (9)

DOI: 10.1128/spectrum.00382-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.09.2025. Verfasst von Michelle Hardman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Manchester Metropolitan University, Manchester, United Kingdom. Hauptthemen laut MEDLINE: Cystic Fibrosis, Mycobacterium Infections, Nontuberculous, Microbiota, Lung. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Trust, Jean Shanks Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nontuberculous mycobacterial (NTM) infections in people with cystic fibrosis (pwCF) can have detrimental effects on prognosis and pose significant challenges to treatment. However, there are still questions regarding the contribution and influence of NTMs on the respiratory microbiome and the mechanisms by which NTMs cause infections. Here, we investigate the impact of NTM infection on microbiome composition and lung function (percent predicted forced expiratory volume in 1 second). Primary comparisons were between culture-positive cohorts for Mycobacterium avium complex and Mycobacterium abscessus complex and those who were culture-negative for NTMs and attending outpatient clinics. Additionally, the consequence of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy status and positive NTM culture was assessed in terms of microbiome change. Our data suggest that the presence of NTM significantly alters the diversity and the composition of the lung microbiota in pwCF, including those receiving CFTR modulator therapies. Importantly, significant associations were detected between NTM presence and changes in abundance of Pseudomonas aeruginosa and Burkholderia cepacia complex members, inferring modulatory effects of NTMs on respiratory microbiomes. This study contributes to the understanding of NTM infection and these organisms’ interaction with the respiratory microbiome and CFTR modulator therapy, highlighting the need for further research in this area. IMPORTANCE The influence of NTM infection in pwCF is still debated, and the extent of their contribution to mortality and morbidity is still questioned. Findings in this study highlight a link between the presence of NTMs and significant alterations in the composition of the respiratory microbiome, particularly with respect to some of the canonical CF pathogens, especially Pseudomonas aeruginosa and members of the Burkholderia cepacia complex. This indicates that complex relationships are occurring within the microbiome. This study further contributes to the understanding of NTM infection in pwCF, with and without CFTR modulator therapy, and highlights the need for further research in this area. The knowledge gained from this study has implications for treatment strategies and management, ultimately aiming to improve and prolong the lives of pwCF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisMycobacterium Infections, NontuberculousMicrobiotaLungNontuberculous MycobacteriaRespiratory Tract InfectionsHumansMaleFemaleAdultCystic Fibrosis Transmembrane Conductance RegulatorYoung AdultMycobacterium abscessusPseudomonas aeruginosa

Stichwörter der Autor:innen

Burkholderia cepacia complexCFTR modulator therapyNontuberculous mycobacteriumPseudomonas aeruginosacystic fibrosismicrobiomerespiratory infection

Substanzen

Cystic Fibrosis Transmembrane Conductance Regulator

Autor:innen und Institutionen

  • Department of Life Sciences, Manchester Metropolitan University, Manchester, United Kingdom.
  • The Grange University Hospital, Cwmbran, Gwent, United Kingdom.
  • Department of Microbiology and Molecular Genetics, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.
  • Division of Pulmonary and Critic, Care Medicine, Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.
  • Wessex Adult Cystic Fibrosis Unit, University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • National Institute for Health Research, Southampton Biomedical Research Centre, Southampton, United Kingdom.

ORCID-Profile: Christopher van der Gast, Damian W Rivett

Förderung

  • Cystic Fibrosis Trust
  • Jean Shanks Foundation

Zitieren

APA

Hardman, M., Higgi, S., Hanson, L., Schutz, K., Wargo, M. J., Teneback, C. C., Daniels, T. W. V., van der Gast, C., & Rivett, D. W. (2025). Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections. Microbiology Spectrum, 13(9). https://doi.org/10.1128/spectrum.00382-25

Vancouver

Hardman M, Higgi S, Hanson L, Schutz K, Wargo MJ, Teneback CC, et al. Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections. Microbiology Spectrum. 2025;13(9). doi:10.1128/spectrum.00382-25

BibTeX
@article{Hardman2025,
  author = {Hardman, Michelle and Higgi, Sarah and Hanson, Liam and Schutz, Kristin and Wargo, Matthew J and Teneback, Charlotte C and Daniels, Thomas W V and van der Gast, Christopher and Rivett, Damian W},
  title = {Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections},
  journal = {Microbiology Spectrum},
  year = {2025},
  volume = {13},
  number = {9},
  doi = {10.1128/spectrum.00382-25}
}
Kostenlos starten →